Residency · Torrance, CA
Sponsored by Los Angeles County-Harbor-UCLA Medical Center
Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial (ADhere).
JAMA dermatology · 2023 · 129 citations · Jennifer Soung
Extramammary Paget disease. Part I. epidemiology, pathogenesis, clinical features, and diagnosis.
Journal of the American Academy of Dermatology · 2024 · 35 citations · Jan Smogorzewski
Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata.
The British journal of dermatology · 2025 · 34 citations · Jennifer Soung
Skin substitutes as treatment for chronic wounds: current and future directions.
Frontiers in medicine · 2023 · 63 citations · Nicole Vecin
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.
American journal of clinical dermatology · 2024 · 52 citations · Jennifer Soung
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis.
The New England journal of medicine · 2021 · 150 citations ·
Malignant peripheral nerve sheath tumor: models, biology, and translation.
Oncogene · 2022 · 102 citations · Lu Le
Cutaneous T-cell lymphoma following dupilumab use: a systematic review.
International journal of dermatology · 2023 · 58 citations · Ariel Park